Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer

Table 1

Laboratory data of posttreatment day 14. Decline of leukocytes, neutrophils, and platelets. Elevation of C-reactive protein. A blood gas analysis did not show any abnormal data.

Laboratory data
Complete blood count
WBC	400	/μL
Neutrophil	130	/μL
RBC	2.97	×10^6/μL
Hb	8.7	g/dL
Hct	25.4	%
Plt	1.0	×10^4/μL
Blood coagulation test
PT	108	%
PT-INR	0.97
APTT	28.3	Seconds
Blood gas analysis
pH	7.46
PaO2	83.0	mmHg
PaCO2	39.3	mmHg
HCO^3	27.3	mmol/L
BE	3.3	mEq/L
Lactate	16	mg/dL
Blood biochemical test
TP	5.2	g/dL
Alb	2.3	g/dL
T-bil	0.7	mg/dL
AST	25	IU/L
ALT	23	IU/L
LDH	233	IU/L
CK	24	IU/L
BUN	19	mg/dL
Creatine	0.5	mg/dL
Na	142	mmol/L
K	3.2	mmol/L
Cl	103	mmol/L
Ca	8.2	mg/dL
CRP	16.5	mg/dL